Mr. Jurnal Reang

Research Interest

• Cancer
• VEGFR-2
• Quinoline nucleus
• In silico studies
• Synthesis

Research articles 

• Sharma, V., Reang, J., Yadav, V., Sharma, P. C., Majeed, J., & Sharma, K. (2025). Discovery of 6-amino pyridine clubbed heterocycles as potent dual GSK-3β/CK-1δ inhibitors for the treatment of Alzheimer's disease. Bioorganic chemistry, 159, 108409. https://doi.org/10.1016/j.bioorg.2025.108409 
• Reang, J., Sharma, K., Sharma, P. C., Yadav, V., Sharma, V., & Majeed, J. (2023). Discovery of VEGFR inhibitors through virtual screening and energy assessment. Journal of biochemical and molecular toxicology, 37(5), e23321. https://doi.org/10.1002/jbt.23321

Review articles

• Reang, J., Sharma, P. C., Thakur, V. K., & Majeed, J. (2021). Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer. Biomolecules, 11(8), 1130. https://doi.org/10.3390/biom11081130
• Yadav, V., Reang, J., Sharma, V., Majeed, J., Jambulingam, S., Goyal, R., & Tonk, R. K. (2021). Repositioning of Drugs as a Promising Strategy to Fight COVID-19. Coronaviruses, 2(9), 6-20.
• Yadav, V., Reang, J., Sharma, V., Majeed, J., Sharma, P. C., Sharma, K., Giri, N., Kumar, A., & Tonk, R. K. (2022). Quinoline-derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review. Chemical biology & drug design, 100(3), 389–418. https://doi.org/10.1111/cbdd.14099
• Sharma, K., Yadav, V., Reang, J., Sharma, K., Tonk, R. K., Jain, P., & Verma, S. (2024). Overview of the Current Advancements and Trends in the Transungual Drug Delivery System. Letters in Drug Design & Discovery, 21(8), 1316-1324.
• Sharma, V., Reang, J., Yadav, V., Majeed, J., Sharma, P. C. (2024). Advancements and application of sustainable nanotechnology-based biomedical products in cancer therapeutics. Nanofabrication, 8.
• Yadav, V., Reang, J., Sharma, P. C., Sharma, K., Kumar, D., & Tonk, R. K. (2024). Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment. European Journal of Medicinal Chemistry Reports, 10, 100142.
• Sharma, V., Chander Sharma, P., Reang, J., Yadav, V., Kumar Tonk, R., Majeed, J., & Sharma, K. (2024). Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach. Bioorganic chemistry, 147, 107378. https://doi.org/10.1016/j.bioorg.2024.107378

• Reang, J., Sharma, V., Yadav, V., Tonk, R. K., Majeed, J., Sharma, A., & Sharma, P. C. (2024). Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy. Medicinal Chemistry Research, 33(7), 1079-1099.

Book chapters

• Yadav, V., Reang, J., Vinita, Tonk, R. K. (2022). Ligand-based drug design (LBDD). In Computer aided drug design (CADD): from ligand-based methods to structure-based approaches (pp. 57-99). Elsevier.
• Majeed, J., Reang, J., Sharma, K., Acharya, P. C., & Sharma, P. C. (2023). Antiamoebic drugs. In Medicinal chemistry of chemotherapeutic agents (pp. 397-429). Academic Press.
• Reang, J., Yadav, V., Vinita, Majeed, J., Sharma, P. C., Tonk, R. K., & Sharma, K. (2023). Informatics: tools and databases in drug discovery. In CADD and informatics in drug discovery (pp. 53-77). Singapore: Springer Nature Singapore.
• Vinita, Reang, J., Yadav, V., Majeed, J., Sharma, P. C., Sharma, K., & Tonk, R. K. (2023). Virtual Screening in Lead Discovery. In CADD and Informatics in Drug Discovery (pp. 123-140). Singapore: Springer Nature Singapore.

Yadav, V., Reang, J., Vinita, & Tonk, R. K. (2023). Artificial intelligence and machine learning in drug discovery. In CADD and Informatics in Drug Discovery (pp. 205-230). Singapore: Springer Nature Singapore.

Qualified GPAT and availed National Fellowship and Scholarship for Higher Education to pursue Ph.D. Degree.